Detalhe da pesquisa
1.
Circulating extracellular vesicle-associated TGFß3 modulates response to cytotoxic therapy in head and neck squamous cell carcinoma.
Carcinogenesis
; 40(12): 1452-1461, 2019 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31436806
2.
RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors.
Curr Cancer Drug Targets
; 23(11): 900-909, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076963
3.
MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers.
Cancer Genet
; 240: 54-58, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31778928
4.
The Brazilian TP53 mutation (R337H) and sarcomas.
PLoS One
; 15(1): e0227260, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978118